Phosphodiesterases in neuronal function (Homo sapiens)

From WikiPathways

Revision as of 17:31, 7 June 2024 by Khanspers (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search
61235synaptic gapLegendrelease of neurotransmitters into synaptic gapbindingstimulationinhibitionmainly responsibleGuanylat cyclases (GC)(soluble)PDEnucleusDopamine receptor D1nAChR (nicotine alpha 7 receptor)PDEsglutamergic neuron NMDA receptornucleus accumbens/caudate-putamenA2Afrontal cortexAMPA receptorPDE4CCyclic GMPCHRNA7GRIN2CPRKG1DRD1PDE11APDE6GADCY9RolipramPRKACAADCY7GRIN2APDE5GTPDRD2Cyclic AMPPDE9AADCY5GRIA1PDE6CNitric oxideADCY10PDE6BGMPADCY8PDE6HAMPCaffeinePDE3APDE3BCilostazolCREBADCY4SildenafiltreatmentADCY1GRIN2BPDE4BPDE4DPDE3ANOS1PDE1APDE5AGRIN1ADCY6ADCY2PDE4APDE10APDE2AADORA2APDE6DSildenafilDARPP-32CAMK2AGRIN2DPDE12DopaminePDE1BPDE3BPDE6APDE7BADCY3PDE8BPDE1CCalciumPDE7APDE8AL-GlutamateL-GlutamateL-GlutamateCyclic AMPDopamineneuron dopamergic neuron from substantianigra pars compacta (SNc)and/or ventral tegmental areaDopaminePDE10APDE4DPDE1BPDE4DL-GlutamateDopaminePRKACADRD2GRIN1GRIN2DGRIN2CGRIN2AGRIN2BAMPAspiny neuronD1 direct pathwayspiny neuron D2 indirect pathwaystriatal interneuronGMPCyclic GMPGMPCyclic GMPPDE1BnucleusCREBPRKG1AMPAGRIN1GRIN2DGRIN2CGRIN2AGRIN2BDRD1nucleusCREBPRKG1GUCY1A2GUCY1B1GUCY1A1GUCY1B2GRIN2AGRIN2CGRIN1GRIN2BGRIN2DDRD1DRD2Dopamine receptor D2GRIA1ADORA2AGUCY1B2GUCY1A3GUCY1B3GUCY1A2Adenylat cyclases (AC)PDE1BPDE10APDE4DADCY2ADCY1AMPCyclic AMPADCY2ADCY1AMPADCY2ADCY1DARPP-32PRKACAADCY2ADCY1AMPCyclic AMPPRKACADARPP-324GUCY1A2GUCY1B1GUCY1A1GUCY1B2GUCY1A2GUCY1B1GUCY1A1GUCY1B2


Description

Phosphodiesterases are enzymes which break phosphodiester bonds and play an importan role in signaling pathways, especially in second messenger pathways which involve cyclic AMP or GMP.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K; ''Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.''; Gene, 1998 PubMed Europe PMC Scholia
  2. Minami N, Suzuki Y, Yamamoto M, Kihira H, Imai E, Wada H, Kimura Y, Ikeda Y, Shiku H, Nishikawa M.; ''Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo.''; Life Sci. , 1997 PubMed Europe PMC Scholia
  3. Kern A, Mavrikaki M, Ullrich C, Albarran-Zeckler R, Brantley AF, Smith RG; ''Hippocampal Dopamine/DRD1 Signaling Dependent on the Ghrelin Receptor.''; Cell, 2015 PubMed Europe PMC Scholia
  4. Heckman PR, van Duinen MA, Bollen EP, Nishi A, Wennogle LP, Blokland A, Prickaerts J; ''''; , PubMed Europe PMC Scholia
  5. Khairallah M, Khairallah RJ, Young ME, Allen BG, Gillis MA, Danialou G, Deschepper CF, Petrof BJ, Des Rosiers C.; ''Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.''; Proc Natl Acad Sci U S A., 2008 PubMed Europe PMC Scholia
  6. Kitabchi AE, Wilson DB, Sharma RK.; ''Steroidogenesis in isolated adrenal cells of rat. II. Effect of caffeine on ACTH and cyclic nucleotide-induced steroidogenesis and its relation to cyclic nucleotide phosphodiesterase (PDE).''; vBiochem Biophys Res Commun. , 1971 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
132625view17:31, 7 June 2024Khanspersupdated incorrect mim-modification to mim-binding
124530view14:17, 5 November 2022EgonwMade a pathway clickable
124484view13:48, 31 October 2022Cenna Doornbos
124483view13:46, 31 October 2022Cenna DoornbosUppdated non-annotated nodes
124482view13:06, 31 October 2022Cenna DoornbosUpdated sildenafil pathway and protein names.
107160view14:24, 17 September 2019MaintBotChEBI identifier normalization
106137view12:03, 16 August 2019MaintBotHMDB identifier normalization
105135view12:00, 10 July 2019EgonwFixed the identifier for L-glutamate (a more accurate record)
96808view11:35, 9 April 2018Fehrhartfixed data node annotation
96231view13:22, 1 March 2018FehrhartOntology Term : 'attention deficit hyperactivity disorder' added !
96230view13:22, 1 March 2018FehrhartOntology Term : 'obsessive-compulsive disorder' added !
96229view13:22, 1 March 2018FehrhartOntology Term : 'Gilles de la Tourette syndrome' added !
96228view13:22, 1 March 2018FehrhartOntology Term : 'Huntington's disease' added !
96227view13:21, 1 March 2018FehrhartOntology Term : 'Parkinson's disease' added !
96226view13:21, 1 March 2018FehrhartOntology Term : 'schizophrenia' added !
96225view13:20, 1 March 2018FehrhartOntology Term : 'Alzheimer's disease' added !
96224view13:19, 1 March 2018FehrhartOntology Term : 'glutamate signaling pathway' added !
96223view13:19, 1 March 2018FehrhartOntology Term : 'dopamine signaling pathway' added !
96222view13:18, 1 March 2018FehrhartOntology Term : 'neuron-to-neuron signaling pathways' added !
96221view13:18, 1 March 2018FehrhartOntology Term : 'neuron' added !
96220view13:17, 1 March 2018Fehrhartwork in progress
96219view11:02, 1 March 2018Fehrhartwork in progress
96218view10:15, 1 March 2018FehrhartModified title
96216view15:31, 28 February 2018Fehrhartwork in progress
96215view15:00, 28 February 2018Fehrhartwork in progress
96214view14:21, 28 February 2018FehrhartNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ADCY10GeneProductENSG00000143199 (Ensembl)
ADCY1GeneProductENSG00000164742 (Ensembl)
ADCY2GeneProductENSG00000078295 (Ensembl)
ADCY3GeneProductENSG00000138031 (Ensembl)
ADCY4GeneProductENSG00000129467 (Ensembl)
ADCY5GeneProductENSG00000173175 (Ensembl)
ADCY6GeneProductENSG00000174233 (Ensembl)
ADCY7GeneProductENSG00000121281 (Ensembl)
ADCY8GeneProductENSG00000155897 (Ensembl)
ADCY9GeneProductENSG00000162104 (Ensembl)
ADORA2AGeneProductENSG00000128271 (Ensembl)
AMPAGeneProductENSG00000155511 (Ensembl)
AMPMetaboliteHMDB0003540 (HMDB)
CAMK2AGeneProductENSG00000070808 (Ensembl)
CHRNA7GeneProductENSG00000175344 (Ensembl)
CREBGeneProductENSG00000118260 (Ensembl)
CaffeineMetaboliteHMDB0001847 (HMDB)
CalciumMetaboliteHMDB0000464 (HMDB)
CilostazolMetaboliteHMDB0015297 (HMDB)
Cyclic AMPMetaboliteHMDB0000058 (HMDB)
Cyclic GMPMetaboliteHMDB0001314 (HMDB)
DARPP-32GeneProductENSG00000131771 (Ensembl)
DRD1GeneProductENSG00000184845 (Ensembl)
DRD2GeneProductENSG00000149295 (Ensembl)
DopamineMetaboliteHMDB0000073 (HMDB)
GMPMetaboliteHMDB0001397 (HMDB)
GRIA1GeneProductENSG00000155511 (Ensembl)
GRIN1GeneProductENSG00000176884 (Ensembl)
GRIN2AGeneProductENSG00000183454 (Ensembl)
GRIN2BGeneProductENSG00000273079 (Ensembl)
GRIN2CGeneProductENSG00000161509 (Ensembl)
GRIN2DGeneProductENSG00000105464 (Ensembl)
GTPMetaboliteCHEBI:37565 (ChEBI)
GUCY1A1GeneProductENSG00000164116 (Ensembl) Also known as GUCY1A3 [uniprot:Q02108].
GUCY1A2GeneProductENSG00000152402 (Ensembl)
GUCY1A3GeneProductENSG00000164116 (Ensembl)
GUCY1B1GeneProductENSG00000061918 (Ensembl) Also known as GUCY1B3 [uniprot:Q02153].
GUCY1B2GeneProductENSG00000123201 (Ensembl)
GUCY1B3GeneProductENSG00000061918 (Ensembl)
L-GlutamateMetaboliteCHEBI:16015 (ChEBI)
NOS1GeneProductENSG00000089250 (Ensembl)
Nitric oxideMetaboliteHMDB0003378 (HMDB)
PDE10AGeneProductENSG00000112541 (Ensembl)
PDE11AGeneProductENSG00000128655 (Ensembl)
PDE12GeneProductENSG00000174840 (Ensembl)
PDE1AGeneProductENSG00000115252 (Ensembl)
PDE1BGeneProductENSG00000123360 (Ensembl)
PDE1CGeneProductENSG00000154678 (Ensembl)
PDE2AGeneProductENSG00000186642 (Ensembl)
PDE3AGeneProductENSG00000172572 (Ensembl)
PDE3BGeneProductENSG00000152270 (Ensembl)
PDE4AGeneProductENSG00000065989 (Ensembl)
PDE4BGeneProductENSG00000184588 (Ensembl)
PDE4CGeneProductENSG00000105650 (Ensembl)
PDE4DGeneProductENSG00000113448 (Ensembl)
PDE5AGeneProductENSG00000138735 (Ensembl)
PDE5GeneProductENSG00000138735 (Ensembl) Also known as PDE5A [uniprot:O76074]
PDE6AGeneProductENSG00000132915 (Ensembl)
PDE6BGeneProductENSG00000133256 (Ensembl)
PDE6CGeneProductENSG00000095464 (Ensembl)
PDE6DGeneProductENSG00000156973 (Ensembl)
PDE6GGeneProductENSG00000185527 (Ensembl)
PDE6HGeneProductENSG00000139053 (Ensembl)
PDE7AGeneProductENSG00000205268 (Ensembl)
PDE7BGeneProductENSG00000171408 (Ensembl)
PDE8AGeneProductENSG00000073417 (Ensembl)
PDE8BGeneProductENSG00000113231 (Ensembl)
PDE9AGeneProductENSG00000160191 (Ensembl)
PRKACAGeneProductENSG00000072062 (Ensembl)
PRKG1GeneProductENSG00000185532 (Ensembl)
RolipramMetaboliteCHEBI:104872 (ChEBI)
Sildenafil treatmentPathwayWP5294 (WikiPathways)
SildenafilMetaboliteHMDB0005039 (HMDB)

Annotated Interactions

No annotated interactions

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP4222"
Personal tools